title: Individualising HIV treatment--pharmacogenetics and immunogenetics.
authors.affiliation: Division of Infectious Diseases, University Hospital, CHUV 1011 Lausanne, Switzerland. Amallo.Telenti@chuv.hospvd.ch
authors.forename: Amalio
authors.initials: A
authors.lastname: Telenti
authors.forename: Vincent
authors.initials: V
authors.lastname: Aubert
authors.forename: François
authors.initials: F
authors.lastname: Spertini
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015224:Dideoxynucleosides / Q000009:adverse effects* / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000235:genetics* / Q000276:immunology; D005820:Genetic Testing; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D006239:Haplotypes; D006801:Humans; D008285:Major Histocompatibility Complex / Q000235:genetics; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000099227:Abacavir
chemical_list: D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir